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Abstract
Prostaglandin F2α (PGF2α) determines luteolysis in cattle, and the ability to manipulate its endogenous synthesis is 
indispensible for large-scale animal breeding. Estradiol (E2) and progesterone (P4) modulate several molecular pathways 
in endometrial cells, including the synthesis of PGF2α; however, its specific mechanisms are still not totally known. 
This study investigated the production in vitro and possible modulation of endometrial PGF2α due to a local effect of 
endogenous E2 in the ipsilateral uterine horn (UH) containing the dominant follicle (DF) or from P4 in ipsilateral horn 
containing the corpus luteum (CL). The PGF2α stimulators oxytocin (OT) and phorbol 12,13-dibutyrate (PDBu) were 
incubated with endometrial explants, and PGF2α content was measured. For that, cycling cows were synchronized, the 
development of DF and CL was examined by ultrasonography and on the seventh day of the estrous cycle, endometrial 
explants were collected and cultured in medium supplemented with 10-6 M PDBu or 10-6 M OT or non-supplemented. 
Media samples were collected immediately after treatment and 60 min later. Radioimmunoassay showed that 
the PGF2α content of the UH ipsilateral to the DF was 49% less than that of the contralateral UH (8.22 ± 0.95 vs. 
12.24 ± 0.95 pg/mL/mg tissue, respectively; P < 0.01). However, the PGF2α levels did not differ between the UHs as 
a function of the CL position (9.46 ± 0.95 vs. 11 ± 0.95 pg/mL/mg; P > 0.05). The cellular stimulators promoted an 
increase in PGF2α synthesis (P < 0.02), and the effects differed among the animals (P < 0.04). The PGF2a production was 
higher in the explants treated with PDBu rather than OT (13.68 ± 1.16 vs. 10.01 ± 1.16 pg/mL/mg tissue, respectively; 
P < 0.05). In conclusion, PGF2α synthesis is modulated by the presence of the DF (local E2) but not the CL (local P4), 
and both PDBu and OT stimulated PGF2a synthesis.
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Resumo
A prostaglandina F2α (PGF2α) determina a luteólise em bovinos. A capacidade de manipular sua síntese endógena é 
indispensável para a produção animal em grande escala. O estradiol (E2) e a progesterona (P4) modulam diversas vias 
moleculares das células endometriais, incluindo a síntese de PGF2α; no entanto, pouco se sabe sobre seus mecanismos 
específicos. Este trabalho investigou a produção in vitro e a possível modulação da PGF2α endometrial devido a um 
efeito local do E2 endógeno no corno uterino ipsilateral ao folículo dominante (FD) ou da P4 no corno ipsilateral ao 
corpo lúteo (CL). Os estimuladores de PGF2α oxitocina (OT) e 12,23-dibutirato de forbol (PDBu) foram incubados 
com explantes endometriais, e o conteúdo de PGF2α foi mensurado. Para tal, vacas cíclicas foram sincronizadas, o 
desenvolvimento de FD e CL foi examinado por ultrassonografia, e no 17º dia do ciclo estral os explantes endometriais 
foram coletados e cultivados em meio ou suplementados com PDBu 10-6M ou 10-6M OT. As amostras de meio foram 
coletadas imediatamente após o tratamento e sessenta minutos depois. O radioimunoensaio mostrou que o conteúdo 
de PGF2α do corno ipsilateral ao FD foi 49% menor que o do corno contralateral (8,22 ± 0,95 vs. 12,24 ± 0,95 pg/mL/mg 
de tecido, respectivamente, P < 0,01). No entanto, os níveis de PGF2α não diferiram entre os cornos em função 
da posição do CL (9,46 ± 0,95 versus 11 ± 0,95 pg/mL/mg; P > 0,05). Os estimuladores celulares promoveram um 
aumento na síntese de PGF2α (P < 0,02), e os efeitos diferiram entre os animais (P < 0,04). A produção de PGF2α foi 
maior nos explantes tratados com PDBu em comparação à OT (13,68 ± 1,16 versus 10,01 ± 1,16 pg/mL/mg de tecido, 
respectivamente, P < 0,05). A conclusão obtida foi que a síntese de PGF2α é: modulada pela presença do FD (E2 local), 
mas não do CL (P4 local); e estimulada por PDBu e OT. 
Palavras-chave: Bovino. Luteólise. Síntese de PGF2α. Fisiologia reprodutiva.
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Introduction
In cattle, the reproductive cycle is determined by a 
well-coordinated set of physiological events. Luteolysis, 
one of these events, is characterized by the functional 
and morphological regression of the corpus luteum (CL) 
resulting in the decline in the plasma concentrations of 
progesterone (P4), favoring the growth of the dominant 
follicle (DF) and an increase in the serum concentrations of 
estradiol (E2); hence, initiating an acute release of luteinizing 
hormone (LH) and ovulation. Prostaglandin F2α (PGF2α) 
is known to be the main luteolytic factor in cows, and it 
has been reported that its action on the CL is probably 
mediated by other factors such as immune and endothelial 
cells and pericytes. In this species, the occurrence of five to 
eight pulsatile releases of PGF2α within an interval of two 
to three days determines luteolysis between days fifteen and 
nineteen of the estrous cycle (MCCRACKEN et al., 1999; 
MEIDAN et al., 1999; SKARZYNSKI; OKUDA, 2010).
The endometrial synthesis of PGF2α results from a 
complex cascade of highly coordinated events involving 
endocrine factors such as estradiol (E2), oxytocin (OT) and 
luteinizing hormone (LH). Molecularly, the arachidonic 
acid (AA) stored in the phospholipid membranes is the 
main primary precursor of prostaglandins (DIAZ et al., 
2002). In the classic model, oxytocin (OT), acting through 
its receptor on the endometrial cell membrane, activates a 
guanosine nucleotide-binding protein (G protein), which 
promotes the activation of phospholipase C (PLC) that 
cleaves phosphatidylinositol triphosphate into inositol 
triphosphate (IP3) and diacylglycerol (DAG). IP3 binds 
to receptors on the endoplasmic reticulum, promoting an 
increase in the cytoplasmic calcium concentration. DAG 
activates protein kinase C (PKC), a serine/threonine kinase 
that is dependent on calcium for activation. Activated PKC 
phosphorylates phospholipase A2 (PLA2). The IP3-induced 
increase in cytosolic calcium stimulates the calcium-
dependent PLA2 activity, and PLA2 preferentially cleaves 
the sn-2 position of phosphatidylcholine, releasing AA. The 
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free AA is then converted into PGG2 by the cyclooxygenase 
(COX, prostaglandin G/H synthase) enzyme. PGG2 is 
converted into PGH2 by a peroxidase and, finally, converted 
into PGF2α by PGF synthase (WLODAWER et al., 1976; 
CLARK   et  al.,   1991; BURNS et al., 1997; GIJÓN; 
LESLIE, 1999). 
Another PGF2α stimulator is the phorbol ester PDBu 
(phorbol 12, 13 dibutyrate [PDBu]). Phorbol esters 
stimulate PKC activity, activates COX-2 gene expression 
and PGF2α secretion via the mitogen-activated protein 
kinase (MAPK) pathway (THATCHER et al., 2001). The 
abilities of PDBu and OT to stimulate PGF2α synthesis in 
bovine endometrial tissue endometrial have been reported 
by Danet-Desnoyers et al. (1994); Mann (2001); Guzeloglu 
et al. (2004) and Rodriguez-Sallaberry et al. (2006). 
The role of endogenous estradiol in this context is not fully 
understood. It was reported that E2 is important for PGF2α 
synthesis during bovine luteolysis and, therefore, for female 
reproductive physiology (KARSCH et al., 1970; IRELAND et 
al., 1984; VILLA-GODOY et al., 1985; HUGHES et al., 1987; 
ZHANG et al., 1991; SALFEN et al., 1999), and it is also 
known that it exerts several other physiological roles in 
the organism (BERKANE et al., 2017; COOKE et al., 2017; 
ZENDEDEL  et  al.,  2017). In cattle, E2 administration 
between days 13 and 18 of the estrous cycle stimulates the 
production of 13,14-dihydro-15-keto-prostaglandin F2α 
(PGFM), the main PGF2α metabolite (LEMON,  1975; 
BARTOL et  al., 1981; KNICKERBOCKER  et al., 1986; 
THATCHER et al., 1986; LARSON et al., 1991). Bertan (2004) 
and collaborators compared the PGF2α synthesis capacity 
after E2 administration on days 15, 17 and 19 of the estrous 
cycle and observed that the magnitude of the E2 response 
progressively increased during this period. 
It is assumed that the triggering of PGF2α synthesis by 
E2 is dependent on a previous and current priming of the 
endometrium by several factors throughout the estrous 
cycle. With respect to the roles of E2 on PGF2α synthesis, 
several studies have reported that E2 induces an increase 
in the numbers of endometrial OT receptors; hence, 
increasing the capacity of the endometrium to respond to 
OT (BEARD; LAMMING, 1994; SPENCER et al., 1995; 
BERIO et al., 2017). 
Progesterone is produced in large amounts by the CL, 
and endometrial priming by P4 is important for PGF2α 
production (VALLET et al., 1990; ZHANG et al., 1991; 
PINEDA; DOOLEY, 2003). It was reported that in the 
absence of previous priming by progesterone, PGF2α 
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synthesis is inhibited (SILVIA; RAW, 1993; LAMMING; 
MANN, 1995; RAW et al., 1995). Bogacki et al. (2002) 
observed that P4 has an inhibitory effect on the production 
and/or activation of OT receptors and on the binding of 
OT to its receptor. 
Although roles for E2 and P4 in PGF2α synthesis 
have been illustrated, the mechanism of action of these 
hormones on luteolysis is still unclear. It is known that E2 
and P4 are present in the systemic circulation and that their 
concentrations vary throughout the estrus cycle, consistent 
with their modulation of cellular mechanisms. However, it 
is also possible that local modulation of PGF2α synthesis 
by E2 and P4 may occur, where the uterine horn ipsilateral 
to the DF would be influenced by locally produced E2 and 
the uterine horn ipsilateral to CL would be influenced by 
the local P4 concentration.
The present work investigated whether endometrial 
explants primed with endogenous E2 or P4 can produce 
PGF2α in vitro when stimulated with OT or PDBu, and 
whether the response would be affected by the dominant 
follicle position (ipsi or contralateral to the endometrial 
explants). These results contribute to a better understanding 
of bovine reproductive physiology and provide new insights 
on bovine endocrine modulation, an essential feature for 
an optimized animal breeding program.
Methods
Non-lactating, non-pregnant and cycling crossbred 
cows (Bos taurus x Bos indicus, n = 5) were maintained 
in grass (Brachiaria decumbens var. marandu) paddocks 
supplemented with minerals and water ad libitum. 
Cows presenting DF and responsive CL received 150 µg 
D-cloprostenol IM (N.C. Preloban® – Intervet) to induce 
estrus. Heat behavior was observed every 12  h for the 
subsequent five days. D0 of the estrus cycle was considered 
the day when estrus was observed. On D6, ultrasonographic 
examinations (Aloka SSD500, 7.5 MHz linear transductor) 
were performed, and females presenting with a DF > 7.5 mm 
received 0.15 mg of a synthetic GnRH analog IM (Fertagyl®) 
to induce DF ovulation, emergence of a new follicular wave 
and occurrence of three-wave cycles. DFs from the second 
follicular wave were observed ultrasonographically on days 
14, 15 and 16 of the estrus cycle. On the 17th day of the 
estrous cycle, the uterine horns were collected from the 
cows at the slaughterhouse, placed in ice and immediately 
brought to the laboratory (approximately 15 min). The 
uterine horns were dissected, endometrial explants from 
both horns collected, and fragments of 80 – 100 mg of 
intercaruncular tissue incubated in borosilicate tubes 
containing 0.5 mL Krebs-Hensleit bicarbonate medium 
(KHB; 118 mM NaCl, 4.7 mM KCl, 2.56 mM CaCl2, 
1.13 mM MgCl2, 25 mM NaHCO3, 1.15 mM NaH2PO4, 
5.55 mM glucose, 20 mM Hepes, 0.013 mM phenol red; 
pH 7.4). The fragments were incubated for 1 h at 37°C and 
40 rpm, washed twice with 0.5 mL KHB and again incubated 
for 1 h and washed. The samples were then incubated in 
1 mL with the in vitro treatments: KHB (control), KHB 
supplemented with 10-6  M OT (Sigma Chemicals O-6379 
reconstituted in acetic acid 5%, final concentration of 0.25 g/
mL) or KHB supplemented with 10-6 M PDBu (Sigma 
Chemicals P-1269; reconstituted in ethanol at 1 mg/mL). 
The treatments were conducted in quadruplicate. The 
concentrations of both stimulators were based on previous 
reports (BURNS  et  al.,  1997; ARNOLD  et al., 2000). 
Aliquots (250 µL) of the culture medium were removed 
immediately after treatment administration (time 0) and 
again after 60 min of incubation. The PGF2α concentrations 
of these samples were analyzed using a radioimmunoassay 
as previously described (DANET-DESNOYERS et al., 1994) 
and average PGF2α production between time 0 and 60 was 
analyzed (DIF 60). 
The PGF2α concentrations at times 0 and 60 were 
adjusted to pg/mL/mg of endometrial tissue. The intra-
assay coefficients of variation for the radioimmunoassay 
for reference samples containing low (250 pg/mL), medium 
(1,000 pg/mL) and high concentrations (3,500 pg/mL) 
were 4.15%, 17.52% and 21.69%, respectively. The inter-
assay coefficients of variation for the low, medium and high 
concentration reference samples were 1.98%, 18.16% and 
26.77%, respectively.
Statistical analysis
Preliminary analysis demonstrated that data was not 
adequate regarding analysis of normality of residues 
(Shapiro-Wilk test, P < 0,01) and variance homogeneity 
(F test, P < 0,01). The data was converted to square roots 
and submitted to variance analysis. The difference between 
the PGF2α concentrations at times 0 and 60 (DIF 60) was 
the dependent variable, and the independent variables were: 
animal, uterine horn (ipsi- or contralateral to DF or CL), in 
vitro treatments and interactions. The data were analyzed 
by ANOVA (proc GLM) (SAS INSTITUTE, 1988) and are 
presented as untransformed LSmeans ± SEM. The means of 
the treatments were compared by specific contrasts.
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Results
A local effect of the presence of the DF was observed 
when endometrial PGF2α content was compared between 
the uterine horns independent of the in vitro stimulation 
(Figure 1). Overall, the PGF2α concentration in the UH 
contralateral to the DF was 49% higher than that of the 
ipsilateral UH (12.24 ± 0.95 vs. 8.22 ± 0.95 pg/mL/mg of 
tissue, respectively; P < 0.01). However, the endometrial 
PGF2α levels were not different between the UHs as a 
function of the position of the CL (Figure 2; 9.46 ± 0.95 vs. 
11 ± 0.95 pg/mL/mg of tissue; P > 0.05).
When both uterine horns were considered, higher PGF2α 
concentrations were observed when the explants were 
treated with PDBu (13.09 ± 1.16 pg/mL/mg of tissue) than 
when they were treated with OT (10.02 ± 1.16 pg/mL/mg 
of tissue) or left untreated (7.59 ± 1.16 pg/mL/mg of tissue; 
P < 0.05) independent of the DF or CL position (Figures 3 
and 4).
Under the conditions of the present investigation, 
large variations in PGF2α production among individuals 
were observed, resulting in an animal effect (P < 0.05). 
An interaction between animal and in vitro treatment was 
observed (P < 0.05). Two of the animals did not respond to 
either OT or PDBu, whereas three responded to both OT 
(minimum of 4.1% and maximum of 60.7%) and PDBu 
(minimum of 37.3% and maximum of 111.8%, data not 
shown). However, no interaction between animal and 
uterine horn was observed. Regardless of the magnitude 
of the PGF2α production, a higher concentration in the 
UH contralateral to the DF was consistently observed. 
Figure 1 –  Effect of DF position (ipsi- or contralateral uterine horns) on average PGF2α 
production of endometrial explants, treated or not (KHB), with OT 10-6M 
or PDBu 10-6M o (DIF 60; LSmeans + SEM). a, b: Different letters represent 
statistical difference
Figure 2 –  Effect of in vitro treatments on endometrial explants from ipsi- or contralateral 
uterine horn to the DF, treated or not (KHB), with OT 10-6M or PDBu 10-
6M on average PGF2α production (DIF 60; LSmeans + SEM). a, b: Different 
letters represent statistical difference
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Discussion
It has been widely reported that the E2 is produced by 
the ovarian follicle due to the interaction between the theca 
cells and the granulosa cells and, after deviation, the DF 
presents higher steroidogenic capacity, resulting in greater 
concentrations of E2 in the follicular fluid (XU et al., 1995; BEG 
et al., 2001). The uterine and ovarian vascularization system 
of the bovine exhibits a particular anatomical feature, an 
entanglement between these vessels that leads to speculation 
regarding a possible local role of E2 from the DF affecting the 
ipsilateral uterine horn. This vein is closely associated with 
the ovarian artery, permitting transport of PGF2α from the 
uterine vein into the ovarian artery by the classic mechanism 
of counterflow (MAPLETOFT; GINTHER, 1975).
Herein it can be speculated that E2 synthesized by the 
DF was, via this counterflow mechanism, transferred 
from uterine vein to the artery, providing E2 in higher 
concentrations to the uterine horn ipsilateral to the ovary 
bearing the DF. Similarly, P4 produced by the CL would 
be provided in higher concentrations to the uterine horn 
ipsilateral to the CL. It is known that both E2 and P4 are 
involved in PGF2α synthesis and are produced in DF and 
CL, respectively. It is therefore plausible to infer a possible 
local action of these hormones that would promote 
endometrial PGF2α synthesis in the uterine horn ipsilateral 
to these structures. 
In the present investigation, greater levels of PGF2α 
synthesis in the UH contralateral to the DF were observed, 
Figure 3 –  Effect of CL position (ipsi- or contralateral uterine horns) on average PGF2α 
production of endometrial explants, treated or not (KHB), with OT 10-6M or 
PDBu 10-6M o (DIF 60; LSmeans + SEM)
Figure 4 –  Effect of in vitro treatments on endometrial explants from ipsi- or 
contralateral uterine horn to the CL, treated or not (KHB), with OT 10-6 M 
or PDBu 10-6M on average PGF2α production (DIF 60; LSmeans + SEM)
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indicating a local modulation of the E2 after PGF2α production 
stimulation. Although the exact mechanisms of action of 
estradiol on PGF2α synthesis are not yet known, a few facts 
about estradiol are already well established. It is known that 
estradiol action is mediated by intracellular receptors, and 
two predominant types of receptors have been characterized: 
α and β estrogen receptors, and the first has been shown as 
the most important subtype for the regulation of uterine 
physiological processes (KUIPER et al., 1996; COUSE; 
KORACH, 1999; WALTHER et al., 1999; MURAMATSU; 
INOUE, 2000). Typically, estradiol exerts its functions by 
binding to its receptors, which act as transcription factors 
(MANGELSDORF et al., 1995) and, therefore, stimulate 
gene transcription and the synthesis of new proteins 
(MANGELSDORF et al., 1995; HO; LIAO, 2002). 
Indeed, it is known that PGF2α production is 
dependent on protein synthesis (BINELLI et al., 2000) 
and, therefore, the presence of different concentrations 
of E2 in each uterine horn, as reported by Ireland et al. 
(1994), is probably highly involved with quantitative and 
qualitative differences on protein synthesis between horns 
and, as a result, in PGF2α production.
Bertan (2004) and collaborators suggested that the 
role of E2 in triggering PGF2α synthesis is dependent on 
previous progressive endometrial priming with several 
factors throughout estrous cycle. It was speculated here 
that during the period in which the PGF2α synthesis was 
higher in the uterine horn contralateral to the DF, lower 
concentrations of the factors responsible for such previous 
priming are probably found in the UH ipsilateral to the 
DF. Lower synthesis capacity of PGF2α production may be 
beneficial to the future pregnant uterine horn. However, 
further studies are needed to unravel the mechanisms 
in which the UH bearing the DF present lower levels of 
PGF2α when stimulated and focusing on blood flow and 
cell-to-cell communication features through extracellular 
vesicles might explain such modulation. Indeed, 
extracellular vesicles such as exosomes or microvesicles 
were already described in body fluid such as seminal 
plasma, uterine fluid and even follicular fluid (BURNS 
et al., 2014; TANNETTA et al., 2014; BRESSAN et al., 
2015). These vesicles contain bioactive molecules such 
as RNAs, miRNAs and proteins that are able to mediate 
physiological processes. For instance, miRNAs involved in 
the regulation of estradiol and progesterone concentrations 
were already reported in exosomes present in the follicular 
fluid in humans (SANG et al., 2013).
PGF2α acts in the developing CL as a local regulator to 
enhance progesterone secretion directly and indirectly by 
stimulating angiogenic factors VEGF and FGF2, probably 
explaining why the developing CL does not acquire 
luteolytic capacity until several days following ovulation 
(MIYAMOTO et al., 2010). Therefore, a possible and yet 
not completely understood endocrine mechanism of 
communication between UHs could explain the similarity 
observed in PGF2α synthesis in both UHs regardless of 
the CL position herein when D17 of the estrous cycle 
was studied. Nevertheless, both UHs showed capacity to 
respond to PGF2α production when stimulated in vitro. 
 Interestingly, greater stimulation of PGF2α synthesis 
in explants treated with PDBu and not OT was observed 
when compared to control. It has been demonstrated that 
oxytocin-stimulated PGF2α secretion is associated with its 
binding to receptors, activity of PKC and the gene expression 
of enzymes involved in PGF2α  synthesis, e.g., PLA2, 
COX-2, and PGFS and that the endometrial sensitivity to 
oxytocin varies during the estrous cycle, presenting high 
responsiveness during the period of luteal regression until 
the early luteal stage of the next estrous cycle (SILVIA et al., 
1991; MIRANDO et al., 1993; OKUDA et al., 2002).
These characteristics may explain the results obtained 
herein, as well as some previous results that did not observe 
a stimulatory effect of OT in endometrial explants retrieved 
from D17 cows (SKARZYNSKI et al., 1999; BERTAN, 2004).
It has been reported that PGF2α produced by the 
endometrial cells is transported through the uterine vein by 
the prostaglandin transporter (PGT), a 12-transmembrane 
solute carrier organic anion transporter protein, and 
activation of ERK1/2 pathways and interactions between 
ERK1/2 and PGT protein appear to be PGT-mediated 
efflux transport function (LEE et al., 2013).
Thatcher et al. (2001) showed that treatment of 
endometrial (BEND) cells with the MEK-1 inhibitor, 
PD98059 completely abolished PDBu-induced secretion of 
PGFα, showing that the PKC-Rafl/MEK-l/ERK1/2 pathway 
was required for PDBu induction of COX-2 activation and 
PGFα, secretion in this model, probably due to activation 
of this pathway through PKC-mediated phosphorylation 
of Raf-1 and subsequent activation of MEK-1 and ERK1/2 
(PRU et al., 2001; THATCHER et al., 2001). In summary, 
different specific mechanisms of action of both OT and 
PDBu, allied with the temporal variation of endometrium 
responsiveness to OT probably lead to different in vitro 
results of PGF2α after stimulation in this study.
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 In the present investigation, PGF2α production varied 
greatly among the animals. Similar effects were also observed 
by Arnold et al. (2000) that used a protocol like the present 
one. An interaction between the animal and the treatment 
was also observed, where the magnitude of the response to 
the stimulators differed among animals. These observations 
suggested that the stimulatory action of both cell stimulators 
might be linked to the presence or absence of a set of proteins 
that comprise the PGF2α-generating cascade. It is possible 
that the magnitude of the response of the endometrial cells 
may be related to the concentrations of these proteins, thus 
generating responses with a wide range of magnitude.
In conclusion, it was demonstrated herein that the 
production of PGF2α in both uterine horns is similar 
regardless of the location of the CL. However, estradiol 
produced by the DF may have a local effect by inhibiting 
PGF2α synthesis. Furthermore, exogenous OT and PDBu 
were able to stimulate PGF2α synthesis in the endometrial 
explants, with PDBu treatment resulting in a greater 
stimulation when compared to control. 
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